-
-
-
Ki-Suck Jung
President, APSR 2022
Local Congress Committee
Professor, Hallym University College of Medicine -
Jae Jeong Shim
Secretary General, APSR 2022
Local Congress Committee
Professor, Korea University College of Medicine -
Jang-Won Sohn
Vice Secretary General, APSR 2022
Local Congress Committee
Professor, Hanyang University College of Medicine -
Kwang Ha Yoo
Vice Secretary General, APSR 2022
Local Congress Committee
Professor, Konkuk University School of Medicine -
Chin Kook Rhee
Vice Secretary General, APSR 2022
Local Congress Committee
Professor, The Catholic University of Korea College of Medicine
-
Speaker's Highlight
-
-
Don Sin
University of British Columbia, St. Paul Hospital (Canada)
Kenneth R. Chapman
Toronto General Hospital Research Institute (Canada)
-
Parameswaran Nair
McMaster University (Canada)
Carolyn Calfee
UCSF (U.S.A.)
-
Gregory P. Downey
University of Colorado School of Medicine (U.S.A.)
David A. Schwartz
University of Colorado School of Medicine (U.S.A.)
-
Neil Schluger
Tuberculosis Control Branch, California Department of Public Health (U.S.A.)
Nick Kim
Critical Care & Sleep Medicine, University of California San Diego (U.S.A.)
-
Nicola Hananiah
Baylor College of Medicine (U.S.A.)
Jae-Joon Yim
Seoul National University College of Medicine (Republic of Korea)
-
Koichiro Asano
Tokai University School of Medicine (Japan)
Diahn-Warng Perng
Taipei Veterans General Hospital (Taiwan)
-
Konstantinos Kostikas
University of Ioannina (Greece)
Karin Klooster
University Medical Center Groningen (Kingdom of the Netherlands)
-
Cough hypersensitivity syndrome: a clinical update
Cough hypersensitivity syndrome describes a troublesome cough caused by an abnormally sensitive airway sensory system. Patients may cough after exposure to perfume, cold air, talking, laughter, smoke, or a light touch in the throat. The symptom can persist even when routine investigations show little evidence of active lung disease.
The condition is increasingly recognised in respiratory medicine, laryngology, allergy, and primary care. It often overlaps with asthma, rhinitis, reflux, vocal cord dysfunction, and post-viral airway irritation, which makes careful assessment more useful than relying on a single test or symptom.
A practical approach combines the patient’s cough history, assessment of treatable traits, exclusion of important pathology, and targeted therapy for neuronal hypersensitivity. Clinical teams attending respiratory congresses such as APSR and KATRD can use this framework to connect emerging research with everyday diagnosis and management.
Recognising the sensory cough pattern
Cough hypersensitivity syndrome commonly presents as a chronic cough lasting more than eight weeks. Patients may describe a tickle, rawness, lump, or irritation in the throat before coughing. Some report that the cough is triggered by ordinary stimuli that would not affect most people, a feature known as allotussia.
Hypertussia, or an excessive cough response to a normally mild irritant, is another important clue. Repeated coughing can create a self-perpetuating cycle: mechanical irritation increases laryngeal sensitivity, which provokes more coughing and further disrupts sleep, work, speech, and social activity.
Women in midlife are frequently represented in specialist cough clinics, although the syndrome can affect people of any age. A recent viral infection, airway inflammation, environmental exposure, or an episode of severe coughing may precede the development of persistent symptoms.
Establishing a focused diagnosis
Diagnosis is clinical and depends on recognising the characteristic symptom pattern while evaluating alternative or coexisting causes. The history should cover timing, triggers, sputum, wheeze, breathlessness, nasal symptoms, heartburn, dysphonia, swallowing difficulty, medication exposure, smoking, and occupational irritants.
Initial testing often includes chest radiography and spirometry, with bronchodilator testing where appropriate. Depending on the presentation, clinicians may consider fractional exhaled nitric oxide, blood eosinophils, bronchial challenge testing, induced sputum, or evaluation by an ear, nose, and throat specialist.
A normal chest X-ray does not prove cough hypersensitivity, but it can reduce concern about several structural causes. Red flags such as haemoptysis, unexplained weight loss, persistent fever, severe dyspnoea, abnormal imaging, recurrent aspiration, or new focal signs require investigation before attributing symptoms to a sensory disorder.
Separating overlapping conditions
Asthma and non-asthmatic eosinophilic bronchitis can produce chronic cough without dramatic wheezing. Upper airway cough syndrome may involve rhinitis, sinus disease, postnasal symptoms, or nasal obstruction. Gastro-oesophageal reflux and laryngopharyngeal reflux are frequently discussed, but empirical acid suppression is most helpful when typical reflux symptoms or objective evidence support it.
Angiotensin-converting enzyme inhibitors are a well-known medication cause and should be reviewed early. Smoking, vaping, airborne particles, and workplace chemicals may maintain airway irritation. In some patients, inducible laryngeal obstruction or dysfunctional breathing contributes to cough and throat symptoms.
The aim is not to force every patient into one diagnostic category. A person may have asthma with a heightened cough response, reflux with laryngeal hypersensitivity, or rhinitis alongside a chronic refractory cough. Identifying and treating these components can improve outcomes without assuming that one explanation accounts for everything.
Treatment that targets the cough circuit
Management begins with education. Explaining that the cough is real, involuntary, and linked to altered sensory processing can reduce fear and help patients participate in behavioural therapy. Trigger avoidance may help, but excessive restriction can reinforce vigilance and disability.
Speech and language therapy delivered by clinicians familiar with chronic cough can teach cough suppression, relaxed throat breathing, vocal hygiene, swallowing strategies, and techniques for managing an urge to cough. This approach is especially useful when laryngeal symptoms, dysphonia, or cough triggered by speaking are prominent.
For persistent symptoms, specialist teams may consider neuromodulators such as gabapentin, pregabalin, or low-dose tricyclic antidepressants. Benefits must be balanced against dizziness, sedation, cognitive effects, and drug interactions. P2X3 receptor antagonists, including gefapixant in jurisdictions where it is available, represent a newer pharmacological direction; taste disturbance and regulatory differences should be discussed openly.
Choosing an individual treatment pathway
Clinical feature Useful assessment Potential management focus Cough triggered by perfume, cold air, or talking Detailed trigger history and cough diary Education, trigger control, cough-control therapy Wheeze or variable airflow limitation Spirometry, bronchodilator response, selected airway tests Evidence-based asthma treatment Nasal congestion or sneezing Nasal examination and allergy history Management of rhinitis or sinus disease Heartburn or regurgitation Symptom review and selected reflux assessment Lifestyle measures and targeted reflux treatment Throat tickle, dysphonia, or swallowing concern Laryngeal examination and speech assessment Laryngeal therapy and aspiration evaluation Persistent cough after treatable traits are addressed Specialist chronic cough review Neuromodulation or emerging antitussive therapy Treatment response should be assessed using outcomes that matter to the patient. Cough frequency, severity, sleep disruption, voice impact, physical activity, and social confidence may change independently. A reduction in cough-related distress can be clinically meaningful even when coughing does not disappear completely.
A cough diary or validated questionnaire can make progress easier to measure. Follow-up also provides an opportunity to review adverse effects, revisit the diagnosis, and identify new warning signs. Lack of improvement should prompt reassessment rather than indefinite escalation of the same therapy.
Practical priorities for clinical teams
A multidisciplinary model is valuable when symptoms cross respiratory, upper-airway, gastrointestinal, and behavioural domains. Respiratory physicians, primary care clinicians, pharmacists, physiotherapists, speech pathologists, and ENT specialists may each contribute a different part of the evaluation.
Clinicians can also use reputable patient care resources when preparing educational material, directing patients to supportive information, or coordinating practical arrangements around specialist care. Clear explanations are particularly important because patients may have experienced repeated tests and unsuccessful treatments.
- Ask specifically about sensory triggers, throat sensations, and cough-related avoidance.
- Review medications, smoking, vaping, occupational exposure, and recent respiratory infections.
- Investigate asthma, eosinophilic airway disease, rhinitis, reflux, and laryngeal disorders when clinically indicated.
- Explain the role of cough-control therapy before presenting medication as the only option.
- Monitor treatment with patient-reported outcomes, adverse-effect reviews, and defined follow-up.
Cough hypersensitivity syndrome is best viewed as a clinical framework rather than a reason to stop investigating. When red flags are absent and common contributors have been addressed, recognising altered cough reflex sensitivity can prevent repeated low-yield treatment cycles and open the door to specialised care.
Respiratory services can incorporate this approach into chronic cough pathways, multidisciplinary clinics, and continuing medical education. A structured assessment, compassionate explanation, and personalised combination of behavioural and pharmacological treatment can help patients regain sleep, communication, mobility, and confidence.
Richard Russell
Nuffield Department of Clinical Medicine, University of Oxford (United Kingdom)
-
Mona Bafadhel
King’s College London (United Kingdom)
David Jackson
Guy’s and St Thomas’ Hospital, King’s College London (United Kingdom)
-
James Chalmers
University of Dundee (United Kingdom)
David Price
University of Aberdeen (United Kingdom)
-